BLFS stock performance?

BioLife Solutions, Inc. (BLFS) news stock charts

BioLife Solutions, Inc. (BLFS/BLFS.OB) Investment Summary:

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of proprietary hypothermic storage and cryopreservation solutions for cells, tissues, and organs. Its proprietary HypoThermosol and CryoStor solutions are marketed to companies, laboratories, and academic institutions involved in research and commercial clinical applications. The company’s line of serum-free and protein-free preservation solutions are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS to decrease the free radical accumulation in cells undergoing hypothermic preservation; and HypoThermosol Purge, an acellul...
www.biolifesolutions.com
10 Employees
Founded in 1987

BIOLIFE SOLUTIONS INC (BLFS:OTC Bulletin Board Market)

LAST $0.10 USD
CHANGE TODAY 0.00 0.00%
VOLUME 8.0K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of BIOLIFE SOLUTIONS INC (BLFS)

OPEN
$0.10
PREVIOUS CLOSE
$0.10
DAY HIGH
$0.10
DAY LOW
$0.10
52 WEEK HIGH
09/15/09 - $0.25
52 WEEK LOW
03/31/09 - $0.05
MARKET CAP
7.0M
AVERAGE VOLUME 10 D
8.9K
EPS TTM
$-0.04
SHARES OUTSTANDING
69.6M
BLFS Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for BIOLIFE SOLUTIONS INC (BLFS)

BioLife Solutions and OriGen Biomedical to Offer Sterile, Pre-Filled Biologic Cell and Tissue Packaging Products to the Cell Therapy and Regenerative Medicine Markets

BioLife Solutions, Inc. and OriGen Biomedical Inc. announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosolR cell and tissue storage/transport media and CryoStorT cryopreservation media. BioLife and OriGen have entered into a non-exclusive, worldwide distribution agreement under which OriGen will purchase BioLife's HypoThermosol and CryoStor products for distribution to OriGen customers. In addition, the parties executed a contract manufacturing services agreement under which BioLife will manufacture OriGen's DMSO and DMSO/Dextran cryopreservation media products under sterile GMP conditions into various packaging options.

BioLife Solutions, Inc. Enters into Amendment to Secured Convertible Multi-Draw Term Loan Facility Agreement

BioLife Solutions, Inc. announced that on December 16, 2009, the company entered into an Amendment to its Secured Convertible Multi-Draw Term Loan Facility Agreement with each of Thomas Girschweiler, a director and stockholder of the company, and Walter Villiger, an affiliate of the company, each a non-U.S. Person pursuant to which (a) the term of the Secured Convertible Multi-Draw Term Loan Note was extended to January 11, 2011, and (b) the conversion feature of the Note was eliminated. The Note previously delivered to each of the Investors also was amended to reflect the changes to the Facility Agreement.

BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement with Centocor Research & Development, Inc

BioLife Solutions, Inc. announced that it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc. The agreement includes the production of a custom variant of BioLife's proprietary serum-free and protein-free CryoStor biopreservation media product, which is formulated with a reduced concentration of 2% DMSO.

BioLife Solutions, Inc. financial resources

otc, otcbb, pinksheet, BLFS, ob BioLife Solutions, Inc.

BLFS Competitors

Company Last Change
Life Technologies Corp $53.33 USD -0.22
Lonza Group AG SFr.86.00 CHF +0.30
Sigma-Aldrich Corp $54.71 USD -0.16
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation BLFS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

BLFS

 | 

BLFS transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About BioLife Solutions, Inc.

BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement

Quote: BLFSNews), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announcedthat it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc.The agreement includes the production of a custom variant of BioLife's proprietary serum-free and protein-free CryoStor biopreservation media product, which is formulated with a reduced concentration of 2% DMSO.http://www.newscom.com/cgi-bin/prnh/20090...
Read article

BioLife Solutions Granted Japanese Biopreservation Patent

Quote: I'm pleased that our research and development activities continue to produce discoveries and potential innovations in the biopreservation field."About BioLife Solutions, Inc.:www.biolifesolutions.com.http://www.marrow.org/This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its manageme...
Read article

BioLife Solutions and OriGen Biomedical to Offer Sterile, Pre-Filled Biologic Cell and Tissue Packaging Products to the Cell Therapy and Regenerative Medicine Markets

Quote: 21 /PRNewswire-FirstCall/ --  BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell...
Read article

BioLife Solutions Achieves ISO 13485 Quality Management Systems Certification

Quote: 23 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has successfully completed audits of its quality systems and GMP production facility in Bothell, Washington by BSI Group and has been issued a certification to ISO 13485:2003, an international standard for quality systems supporting the design, development, and manufacture of medical devic...
Read article

BioLife Solutions and OriGen Biomedical to Offer Sterile, Pre-Filled Biologic Cell and Tissue Packaging Products to the Cell Therapy and Regenerative Medicine Markets

Quote: 21 /PRNewswire-FirstCall/ --  BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell...
Read article

BioLife Solutions Achieves ISO 13485 Quality Management Systems Certification

Quote: 23 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has successfully completed audits of its quality systems and GMP production facility in Bothell, Washington by BSI Group and has been issued a certification to ISO 13485:2003, an international standard for quality systems supporting the design, development, and manufacture of medical devic...
Read article

BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement

Quote: BLFSNews), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announcedthat it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc.The agreement includes the production of a custom variant of BioLife's proprietary serum-free and protein-free CryoStor biopreservation media product, which is formulated with a reduced concentration of 2% DMSO.http://www.newscom.com/cgi-bin/prnh/20090...
Read article

BIOLIFE SOLUTIONS INC Files SEC form 10-Q, Quarterly Report

Quote:
Read article

BIOLIFE SOLUTIONS INC Files SEC form 10-Q, Quarterly Report

Quote:
Read article

BioLife Solutions Announces HypoThermosol(R) and CryoStor(TM) Distribution Agreement With Sigma-Aldrich

Quote: BLFSNews), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that Sigma-Aldrich® will distribute the Company's proprietary HypoThermosol and CryoStor biopreservation media products under the terms of a non-exclusive distribution agreement.http://www.newscom.com/cgi-bin/prnh/20090814/BIOLIFELOGO)Mike Rice, BioLife's chairman and CEO, noted, "We're pleased to have Sigma-Aldrich as a distribution partner for our biopreservat...
Read article

BIOLIFE SOLUTIONS INC Files SEC form 10-Q/A, Quarterly Report

Quote:
Read article

BIOLIFE SOLUTIONS INC Files SEC form 10-Q, Quarterly Report

Quote:
Read article

BioLife Solutions Granted Japanese Biopreservation Patent

Quote: I'm pleased that our research and development activities continue to produce discoveries and potential innovations in the biopreservation field."About BioLife Solutions, Inc.:www.biolifesolutions.com.http://www.marrow.org/This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its manageme...
Read article

BIOLIFE SOLUTIONS INC Files SEC form 10-Q, Quarterly Report

Quote:
Read article

Would you like to leave a comment about BioLife Solutions, Inc. BLFS/BLFS.OB

Besides BioLife Solutions, Inc.'s Stock there is more great penny stock and market information at Realpennies